| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.037 | 0.2 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.2 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.21 | 0.2 |